Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
December 24, 2008- Tokyo - Ajinomoto Co., Inc. (Headquarters: Tokyo, President & CEO: Norio Yamaguchi) and Astellas Pharma Inc. (Headquarters: Tokyo, President & CEO: Masafumi Nogimori) announced...
Japan, December 15, 2008 – Astellas Pharma Inc. (Headquarters: Tokyo, President and CEO: Masafumi Nogimori, hereinafter called the “the Company”) announced that it completed acquisition of...
Japan, November 20, 2008 - Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori, “Astellas”) announced today that an injectable antibiotic, in-licensed from...
Japan, November 18, 2008 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it has established its subsidiary, Astellas Pharma India...
Follow us
